AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 154 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $47,042,000 | -41.4% | 1,368,095 | -49.1% | 0.02% | -43.8% |
Q3 2014 | $80,300,000 | +55.6% | 2,690,116 | +4.6% | 0.03% | +60.0% |
Q2 2014 | $51,599,000 | -13.1% | 2,572,209 | +17.8% | 0.02% | -16.7% |
Q1 2014 | $59,351,000 | +24.3% | 2,183,604 | -5.2% | 0.02% | +26.3% |
Q4 2013 | $47,763,000 | -9.1% | 2,304,043 | -20.2% | 0.02% | -17.4% |
Q3 2013 | $52,533,000 | +10.6% | 2,886,443 | +1.1% | 0.02% | +4.5% |
Q2 2013 | $47,491,000 | – | 2,855,567 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 2,847,842 | $47,362,000 | 5.59% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,850,644 | $80,671,000 | 3.80% |
KING INVESTMENT ADVISORS INC/TX | 491,465 | $8,174,000 | 3.39% |
SECTOR GAMMA AS | 684,724 | $11,388,000 | 3.32% |
Healthcare Value Capital, LLC | 274,481 | $4,565,000 | 3.31% |
Broadfin Capital, LLC | 800,000 | $13,305,000 | 2.60% |
Healthcare Value Capital, LLC | 150,000 | $2,495,000 | 1.81% |
Artal Group S.A. | 2,637,200 | $43,859,000 | 1.38% |
Proxima Capital Management, LLC | 355,722 | $5,916,000 | 1.37% |
Manatuck Hill Partners, LLC | 414,000 | $6,885,000 | 0.84% |